Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AGM 2022- Agenda and Plans

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Jun 06, 2022 9:55am

197 Views

Post# 34733739

RE:RE:AGM 2022- Agenda and Plans

Thanks Pandora, I am still trying to get a handle on the "Annual & Special" event. Hope to see some serious input from our Medical Advisory Board. Specifically Dr. Jewett and Dr. Kulkarni who have an inside track to all measurable clinical test results. Any report on the Vaccine front from Dr. Coombs or from PHAC or National Microbiology Lab would be an added bonus.. Still don't understand today's short selling ??

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand